In this study, Runx3 restoration in a mouse lung cancer model regressed K-Ras-activated ADs as well as ADCs, suppressed secondary oncogene activation, and markedly extended the survival of mice (by approximately 15 weeks). This evidence concerns the gene RUNX3 and lung cancer.